IN2011KN02819A - - Google Patents

Info

Publication number
IN2011KN02819A
IN2011KN02819A IN2819KON2011A IN2011KN02819A IN 2011KN02819 A IN2011KN02819 A IN 2011KN02819A IN 2819KON2011 A IN2819KON2011 A IN 2819KON2011A IN 2011KN02819 A IN2011KN02819 A IN 2011KN02819A
Authority
IN
India
Prior art keywords
relates
humans
animals
viruses
field
Prior art date
Application number
Other languages
English (en)
Inventor
Nigel Dimmock
Andrew Easton
Original Assignee
Univ Warwick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Warwick filed Critical Univ Warwick
Publication of IN2011KN02819A publication Critical patent/IN2011KN02819A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16162—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN2819KON2011 2008-12-12 2009-12-08 IN2011KN02819A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0822672.2A GB0822672D0 (en) 2008-12-12 2008-12-12 Anti-viral protection with viruses containing a defective genome
PCT/GB2009/051666 WO2010067109A1 (en) 2008-12-12 2009-12-08 Anti-viral protection with viruses containing defective genome segments

Publications (1)

Publication Number Publication Date
IN2011KN02819A true IN2011KN02819A (zh) 2015-07-10

Family

ID=40325992

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2819KON2011 IN2011KN02819A (zh) 2008-12-12 2009-12-08

Country Status (11)

Country Link
US (1) US8691215B2 (zh)
EP (1) EP2355834B1 (zh)
CN (1) CN102256611B (zh)
AU (1) AU2009326204B2 (zh)
CA (1) CA2746495C (zh)
DK (1) DK2355834T3 (zh)
ES (1) ES2423193T3 (zh)
GB (1) GB0822672D0 (zh)
IN (1) IN2011KN02819A (zh)
PL (1) PL2355834T3 (zh)
WO (1) WO2010067109A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007253033B2 (en) 2006-05-24 2013-01-24 The University Of Warwick Defective interfering virus
GB2522615A (en) * 2014-01-16 2015-08-05 Univ Warwick Assay and medicament
EP3784789A4 (en) * 2018-04-26 2022-03-30 The University of Hong Kong NUCLEIC ACID MOLECULES AND DUAL PURPOSE PEPTIDES HAVING ANTIVIRAL ACTIVITY AND DELIVERY ACTIVITY AND RELATED COMPOSITIONS AND METHODS
GB202209861D0 (en) * 2022-07-05 2022-08-17 Univ Court Univ St Andrews Viral vectors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8715940B2 (en) 1999-04-06 2014-05-06 Wisconsin Alumni Research Foundation Method of making recombinant influenza virus
ES2633471T3 (es) 2004-10-06 2017-09-21 Medimmune, Llc Composiciones de vacuna contra la gripe estables a temperatura de refrigerador
EP1812564A2 (en) 2004-11-11 2007-08-01 Solvay Pharmaceuticals B.V. Defective influenza virus particles
GB2437799B (en) * 2006-05-24 2008-08-13 Univ Warwick Defective interfering virus
AU2007253033B2 (en) 2006-05-24 2013-01-24 The University Of Warwick Defective interfering virus

Also Published As

Publication number Publication date
EP2355834B1 (en) 2013-05-01
DK2355834T3 (da) 2013-07-29
EP2355834A1 (en) 2011-08-17
US20110243896A1 (en) 2011-10-06
AU2009326204A1 (en) 2011-06-23
CN102256611B (zh) 2014-05-21
WO2010067109A1 (en) 2010-06-17
CA2746495C (en) 2018-04-17
AU2009326204B2 (en) 2014-01-09
GB0822672D0 (en) 2009-01-21
PL2355834T3 (pl) 2014-03-31
CA2746495A1 (en) 2010-06-17
CN102256611A (zh) 2011-11-23
US8691215B2 (en) 2014-04-08
ES2423193T3 (es) 2013-09-18

Similar Documents

Publication Publication Date Title
MX2018014573A (es) Vacuna contra el virus del zika.
MX2013003634A (es) Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales.
CY1114356T1 (el) Αναστολεις του ιου της ηπατιτιδας c
EA201391519A1 (ru) 2'-замещенные нуклеозидные производные и способы их применения для лечения вирусных заболеваний
WO2013039861A3 (en) Engineered nucleic acids and methods of use thereof
EA201100390A1 (ru) Соединения для лечения гепатита с
MX2012004032A (es) Compuestos para el tratamiento de hepatitis c.
EA201390060A1 (ru) Аннелированные пиримидины и триазины и их применение для лечения и/или профилактики сердечно-сосудистых заболеваний
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
WO2009129470A3 (en) Methods for treating herpes virus infections
EA201001691A1 (ru) Антитела к гранулоцитарно-макрофагальному колониестимулирующему фактору
MX350282B (es) Molecula de union que tiene actividad neutralizadora del virus de la influenza a, producida a partir de celulas b humanas.
ATE547118T1 (de) Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung
UA96412C2 (ru) Применение комбинации вируса миксомы и рапамицина для лечения
MX2014000567A (es) Tratamiento de lesion por radiacion utilizando celulas adherentes derivadas del amnios.
MX2013000242A (es) Tratamiento de enfermedades relacionadas con el virus de hepatitis c que usa hidroxicloroquina o una combinacion de hidroxicloroquina y un agente antiviral.
PH12016500465A1 (en) Deoxynojirimycin derivatives and methods of their using
MX2012007166A (es) Composicion antiviral sinergica y su uso.
EA201170484A1 (ru) Терапевтический режим лечения гепатита, включающий пэг-интерферон, рибавирин и vx-950
ATE555108T1 (de) Polyamide zur behandlung des menschlichen papilloma-virus
IN2011KN02819A (zh)
WO2015054678A3 (en) Human papilloma virus therapeutic vaccine
DK2327764T3 (da) Ny klon af Newcastle disease-virus, dens fremstilling og dens anvendelse ved medicinsk behandling af cancer
CA2904533C (en) Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells
MX347911B (es) Vacuna contra virus de diarrea viral de bovinos.